Address: PO box 336 Wierda Park 0149 South Africa
Tel: +27 (0)12 668 3021
Web: http://www.mcpharma.co.za/
MC Pharma (Pty) Ltd., is a pharmaceutical company licensed in terms of Section 22C of the Medicines and Related Substances Act 101 of 1965, and offers the services of an Applicant and Holder of the Registration Certificate (Marketing Authorisation holder), on behalf of a Principal or product owner.
MC Pharma does not own, wholesale or distribute product and the Principal is at all times deemed to be the owner of the medicinal product(s). Commercialisation activities are delegated, by means of agreements, to competent and licenced companies in South Africa, with the approval of the Principal or product owner.
MC Pharma is proud to represent, and to service global customers and Principals from such countries as Australia, the USA, Brazil, EU and UK.
SERVICES INCLUDE:
1. Reviewing formulation ingredients for claim and labeling compliance;
2. Advertising compliance: avoid the embarrassment and consequences of having a
published advertisement found to be in conflict with local requirements.
We screen promotional material giving confidence that marketing and advertising
complies with local regulatory standards;
3. Regulatory liaison with the Regulatory Authority(ies);
4. GMP and Quality Assurance consultations;
5. GMP assessments of manufacturing, packaging and distribution facilities;
6. Technical agreements with 3rd party contractors: we will facilitate in the setting up of
and establishing the required technical agreements with: –
• Manufacturers and Packers,
• Laboratories,
• Warehouses,
• Distributors,
• Printers,
• Advertising agencies
• Marketing Agencies
7. Pharmacovigilance
OTHER SERVICES INCLUDE:
In-licensing of products for local commercialisation utilizing Marketing Authorisations under MC Pharma’s name;
Facilitation of product acquisition, including the evaluation of registration dossiers and supporting regulatory and registration documentation;
Product feasibility and positioning;
Market assessment and analysis
Commercialisation of product including marketing;
Representative training
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
The CEO of Pharma Dynamics explains why the company was the perfect match for Lupin, as the fastest growing, and largest independently owned acquirable pharmaceutical business in South Africa, why…
The chairman of PHARMISA reveals how pharmaceuticals has been designated as one of eight priority sectors of South African Government’s Industrial Policy Action Plan (IPAP), how South African life expectancy…
The CEO of Pierre Fabre for South Africa reveals how his focus has been on marketing the company brand locally, why the goal of the company is to develop business…
The EO of SAMED discusses recent regulations surrounding the medical device industry in South Africa, why South Africa remains the hub and the major gateway to Africa for medical devices…
The managing director of UTi Pharma reveals how UTi is no longer just an international forwarding company but covers a broad spectrum of activities; why as global business increases it…
The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical…
The country manager for BMS South Africa talks about the company’s first to market strategy, and how BMS has shifted the treatment paradigm for oncology in South Africa. Through our platform, we introduce the…
Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African…
Peter Fuller provides us with an update on the integration of Covidien businesses, and explains how Medtronic is bringing innovation to South African patients and contributing to the improvement of the…
Adv. Leslie Sedibe, CEO of Proudly South African explains how the Proudly South African campaign aims to promote local products and services to ultimately address unemployment, and what his main…
The country president of Novartis South Africa reveals how Novartis has recently moved to new premises, demonstrating a clear commitment to continue investing in the country; why South Africa…
The managing director at Adcock Ingram Critical Care reveals the company’s unique business model. As a long-established division within Adcock Ingram, Critical Care operates with relative independence. What is the relationship…
See our Cookie Privacy Policy Here
